<DOC>
	<DOC>NCT00595231</DOC>
	<brief_summary>This is an eight week, randomized, double blind, placebo-controlled, exploratory study. Patients randomized to rufinamide (SYN111) will receive 250 mg BID (total daily dose 500mg) for one week then have their dose increased to 500 mg BID (total daily dose 1000mg) for the remaining 7 weeks of the study. If the 500 mg BID dose is not tolerated, one dose reduction is allowed.</brief_summary>
	<brief_title>Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD)</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>Outpatient 1865 Meet DSM IV criteria for GAD Have moderate to severe anxiety Sign IRB approved consent and can comply with visits and procedures Women of childbearing potential must use acceptable method of contraception Have diagnosis of adjustment disorder or anxiety disorder NOS Have diagnosis of specific phobia Have diagnosis of antisocial personality disorder or other Axis II Disorder Have diagnosis of substance abuse disorder within 3 months of study entry Have diagnosis of major depressive disorder or panic disorder within 6 months of study entry Have diagnosis of PTSD, eating disorder substance dependence disorder within 12 months of study entry Have diagnosis anytime during lifetime of schizophrenia or other psychotic disorder, bipolar mood disorder,OCD, psychosurgery Require medication to treat GAD other than study medication Failed to show improvement with past treatment for GAD Excessively consume caffeine Are receiving treatment with prohibited medications Uncontrolled thyroid condition Positive urine drug screen Obese Clinically significant ECG finding Participating in other clinical trial Clinically significant out of range lab value Past exposure to rufinamide Pregnant or nursing females</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>GAD</keyword>
</DOC>